Package Leaflet: Information for the User
Hirobriz Breezhaler 150 micrograms inhalation powder (hard capsule)
Hirobriz Breezhaler 300 micrograms inhalation powder (hard capsule)
indacaterol
Read the entire package leaflet carefully before starting to use this medication, as it contains important information for you.
Contents of the Package Leaflet
What is Hirobriz Breezhaler
Hirobriz Breezhaler contains the active ingredient indacaterol, which belongs to a group of medications called bronchodilators. When inhaled, it relaxes the muscles of the small airways in the lungs. This helps to open up the airways, making it easier to breathe in and out.
What Hirobriz Breezhaler is used for
Hirobriz Breezhaler is used to facilitate breathing in adult patients who have difficulty breathing due to a lung disease called chronic obstructive pulmonary disease (COPD). In COPD, the muscles surrounding the airways contract, making breathing difficult. This medication relaxes these muscles in the lungs, making it easier to breathe in and out.
Do not use Hirobriz Breezhaler
Warnings and precautions
Consult your doctor or pharmacist before starting to use Hirobriz Breezhaler
During treatment with Hirobriz Breezhaler,
Children and adolescents
Hirobriz Breezhaler should notbe administered to children or adolescents under 18 years of age.
Other medications and Hirobriz Breezhaler
Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medication.
Especially, inform your doctor if you are using:
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
You should not use Hirobriz Breezhaler unless your doctor advises you to. Consult your doctor or pharmacist before using any medication.
Driving and using machines
Hirobriz Breezhaler is unlikely to affect your ability to drive or use machines.
Hirobriz Breezhaler contains lactose
This medication contains lactose (milk sugar). If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Follow the instructions for administration of this medication indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Amount of Hirobriz Breezhaler to use
How to use Hirobriz Breezhaler
If you use more Hirobriz Breezhaler than you should
If you have inhaled too much Hirobriz Breezhaler or if someone uses your capsules, inform your doctor immediately or go to the nearest emergency center. Show the Hirobriz Breezhaler package. Medical attention may be necessary. You may notice that your heart beats faster than normal, or you may have a headache, feel drowsy, nauseous, or vomit.
If you forget to use Hirobriz Breezhaler
If you forget to inhale a dose, inhale one at the usual time the next day. Do not inhale a double dose to make up for missed doses.
How long you should continue your treatment with Hirobriz Breezhaler
Consult your doctor or pharmacist if you have any doubts about how long you should continue your treatment with Hirobriz Breezhaler.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone experiences them.
Some side effects can be serious. Inform your doctor immediately
Other side effects may include:
Very common side effects (may affect more than 1 in 10 patients)
Common side effects (may affect up to 1 in 10 patients)
Uncommon side effects (may affect up to 1 in 100 patients)
Some people may occasionally cough shortly after inhaling the medication. Coughing is a common symptom in COPD. If you experience coughing shortly after inhaling the medication, do not worry. Check your inhaler to see if the capsule is empty and that you have received the full dose. If the capsule is empty, there is no need to worry. If the capsule is not empty, inhale again as indicated.
Reporting side effects
If you experience any side effects, consult your doctor, pharmacist, or nurse, even if they are not listed in this package leaflet. You can also report them directly through the national reporting system included in Appendix V. By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date stated on the carton and blister pack after "EXP". The expiration date is the last day of the month indicated.
Do not store above 30°C.
Store in the original packaging to protect from moisture and do not remove until just before use. Do not use this medication if you notice that the packaging is damaged or shows signs of deterioration.
Medications should not be disposed of through wastewater or household waste. Ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.
Hirobriz Breezhaler Composition
Appearance of Hirobriz Breezhaler and Package Contents
In this package, you will find an inhaler, along with capsules in a blister pack. The capsules are transparent (colorless) and contain a white powder.
"IDL 150" printed in blackabove a blackline and the company logo () printed in blackbelow it.
The following package sizes are available:
Carton containing 10 capsules and 1 inhaler. Carton containing 30 capsules and 1 inhaler.
Multiple package containing 2 packages (each containing 30 capsules and 1 inhaler). Multiple package containing 3 packages (each containing 30 capsules and 1 inhaler). Multiple package containing 30 packages (each containing 10 capsules and 1 inhaler).
Only some package sizes may be marketed.
Marketing Authorization Holder
Novartis Europharm Limited Vista Building
Elm Park, Merrion Road Dublin 4
Ireland
ManufacturerNovartis Pharma GmbH Roonstraße 25
D-90429 Nuremberg Germany
Novartis Farmacéutica SA
Gran Via de les Corts Catalanes, 764
08013 Barcelona
Spain
Novartis Pharma GmbH
Sophie-Germain-Strasse 10
90443 Nürnberg
Germany
You can request more information about this medicine by contacting the local representative of the Marketing Authorization Holder:
Belgium Novartis Pharma N.V. Tel: +32 2 246 16 11 | Lithuania SIA Novartis Baltics Lietuvos filialas Tel: +370 5 269 16 50 |
Luxembourg Novartis Pharma N.V. Tel: +32 2 246 16 11 | |
Czech Republic Novartis s.r.o. Tel: +420 225 775 111 | Hungary Novartis Hungária Kft. Pharma Tel.: +36 1 457 65 00 |
Denmark Novartis Healthcare A/S Tlf: +45 39 16 84 00 | Malta Novartis Pharma Services Inc. Tel: +356 2122 2872 |
Germany Novartis Pharma GmbH Tel: +49 911 273 0 | Netherlands Novartis Pharma B.V. Tel: +31 88 04 52 111 |
Estonia SIA Novartis Baltics Eesti filiaal Tel: +372 66 30 810 | Norway Novartis Norge AS Tlf: +47 23 05 20 00 |
Greece Novartis (Hellas) A.E.B.E. Tel: +30 210 281 17 12 | Austria Novartis Pharma GmbH Tel: +43 1 86 6570 |
Spain Laboratorios Farmacéuticos ROVI, S.A. Tel.: +34 91 375 62 30 | Poland Novartis Poland Sp. z o.o. Tel.: +48 22 375 4888 |
France Novartis Pharma S.A.S. Tel: +33 1 55 47 66 00 | Portugal Novartis Farma - Produtos Farmacêuticos, S.A. Tel: +351 21 000 8600 |
Croatia Novartis Hrvatska d.o.o. Tel. +385 1 6274 220 | Romania Novartis Pharma Services Romania SRL Tel: +40 21 31299 01 |
Ireland Novartis Ireland Limited Tel: +353 1 260 12 55 | Slovenia Novartis Pharma Services Inc. Tel: +386 1 300 75 50 |
Iceland Vistor hf. Tel: +354 535 7000 | Slovakia Novartis Slovakia s.r.o. Tel: +421 2 5542 5439 |
Italy Novartis Farma S.p.A. Tel: +39 02 96 54 1 | Finland Novartis Finland Oy Tel: +358 (0)10 6133 200 |
Cyprus Novartis Pharma Services Inc. Tel: +357 22 690 690 | Sweden Novartis Sverige AB Tel: +46 8 732 32 00 |
Latvia SIA Novartis Baltics Tel: +371 67 887 070 | United Kingdom (Northern Ireland) Novartis Ireland Limited Tel: +44 1276 698370 |
Date of last revision of this leaflet:
Other sources of information
Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu
HIROBRIZ BREEZHALER INHALER INSTRUCTIONS FOR USE
Read the complete Instructions for Use before using Hirobriz Breezhaler.
Insert | Pierce and release | Inhale deeply | Check that the capsule is empty |
Step 1a: Remove the cap. Step 1b: Open the inhaler | Step 2a: Pierce the capsule once Hold the inhaler in a vertical position. Pierce the capsule by pressing both buttons firmly at the same time. You should hear a noise when the capsule is pierced. Pierce the capsule only once. Step 2b: Release the buttons completely | Step 3a: Exhale completely Do not blow into the inhaler. Step 3b: Inhale the medicine deeply Hold the inhaler as shown in the figure. Insert the mouthpiece into your mouth and close your lips firmly around it. Do not press the buttons | Check that the capsule is empty Open the inhaler to check if there is any powder left in the capsule. If there is powder left in the capsule:
|
Step 1c: Remove the capsule Remove a capsule from the blister pack. Do not swallow the capsule. | Inhale quickly and as deeply as possible. During inhalation, you will hear a humming noise. You may notice the taste of the medicine when you inhale. Step 3c: Hold your breath Hold your breath for 5 seconds. | Remove the empty capsule Discard the empty capsule in your household trash. Close the inhaler and put the cap back on. | |
Step 1d: Insert the capsule Never place the capsule directly into the mouthpiece. Step 1e: Close the inhaler | Important Information
|
Your Hirobriz Breezhaler package contains:
| Frequently Asked Questions Why did the inhaler not make a noise when I inhaled? The capsule may be stuck in the compartment. If this happens, carefully release the capsule by tapping the base of the inhaler. Inhale the medicine again, repeating steps 3a to 3c. What should I do if there is powder left in the capsule? You have not received enough of your medicine. Close the inhaler and repeat steps 3a to 3c. I coughed after inhaling, is it important? It may happen. If the capsule is empty, it means you have received enough of your medicine. I notice small fragments of the capsule on my tongue, is it important? It may happen. It is not harmful. The likelihood of the capsules breaking into pieces increases if the capsule is pierced more than once. | Cleaning the Inhaler Wipe the mouthpiece from the inside and outside with a clean, dry cloth that does not leave lint to remove any powder residue. Keep the inhaler dry. Never wash your inhaler with water. |
Disposal of the Inhaler after Use Each inhaler should be discarded after all the capsules have been used. Ask your pharmacist how to dispose of medicines and inhalers that are no longer needed. |
The average price of HIROBRIZ BREEZHALER 150 micrograms POWDER FOR INHALATION (HARD CAPSULE) in October, 2025 is around 50.13 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.